Related Experiment Video
Updated: Aug 17, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System
Published on: May 5, 2018
Cyanotic congenital heart disease and coronary artery atherogenesis
Alistair Fyfe1, Joseph K Perloff, Koichiro Niwa
1Dallas Heart Group, Dallas, TX, USA.
Insights
Adults with cyanotic congenital heart disease (CCHD) exhibit antiatherogenic changes, including low cholesterol and unobstructed coronary arteries. These findings suggest a genetic link to hypocholesterolemia, protecting against atherosclerosis.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Lipid Metabolism
Background:
- High-altitude residents with hypoxemia and erythrocytosis show reduced coronary atherosclerosis and low cholesterol.
- Cyanotic congenital heart disease (CCHD) presents a similar physiological state, but its impact on coronary atherosclerosis is unestablished.
Purpose of the Study:
- To investigate the incidence of coronary atherosclerosis in adults with CCHD.
- To identify potential antiatherogenic mechanisms in CCHD patients, including hypocholesterolemia.
Main Methods:
- 279 patients with CCHD were categorized into four groups based on cyanosis status and surgical intervention.
- Coronary arteries were assessed via angiography in 59 patients and necropsy in 5 subjects.
- Serum total cholesterol levels were measured and compared across groups.
Main Results:
- 58% of cyanotic, non-operated patients (Group A) and 52% of operated, now acyanotic patients (Group B) had low cholesterol (<160 mg/dl), significantly lower than acyanotic controls (Groups C & D, p <0.000001).
- Angiography revealed dilated, unobstructed coronary arteries.
- Necropsy showed ectatic coronary arteries with medial structural abnormalities, but no atherosclerosis.
Conclusions:
- Adults with CCHD exhibit significant antiatherogenic changes, characterized by atheroma-free coronary arteries and hypocholesterolemia.
- Hypocholesterolemia, combined with upregulated nitric oxide, hyperbilirubinemia, hypoxemia, and low platelet counts, likely prevents atherosclerosis in CCHD.
- Persistent hypocholesterolemia after corrective surgery suggests a potential genetic basis.
Abstract:
Hypoxemic erythrocytotic residents of high altitudes lack coronary atherosclerosis and have low cholesterol levels. It was postulated that hypoxemic erythrocytotic adults with cyanotic congenital heart disease (CCHD) might be analogous. The incidence of coronary atherosclerosis in this patient population has not been established, and hypocholesterolemia has not previously been recognized. Accordingly, 279 patients were divided into 4 groups: group A: 143 cyanotic patients not operated on (54 men and 89 women, aged 18 to 69 years); group B: 47 cyanotic patients (28 men and 19 women rendered acyanotic by operation at age 22 to 69 years); group C: 41 acyanotic patients not operated on (22 men and 19 women, aged 22 to 75 years); and group D: 48 patients acyanotic before and after operation (24 men and 24 women, aged 21 to 70 years). Coronary arteries were studied angiographically in 59 patients and at necropsy in 5 subjects aged 37 to 56 years. Total cholesterol was <160 mg/dl in 58% of group A, 52% of group B, 10% of group C, and 12% of group D (p <0.000001, chi-square analysis). Angiograms disclosed dilated coronary arteries without obstruction. Necropsy disclosed ectatic coronary arteries with structural abnormalities of the media. In conclusion, this study provides the first quantitative and qualitative data on antiatherogenic changes in lipoproteins in adults with CCHD. The coronary arteries are atheroma free because hypocholesterolemia acts in concert with the antiatherogenic properties of upregulated nitric oxide, hyperbilirubinemia, hypoxemia, and low platelet counts. The persistence of hypocholesterolemia after the surgical elimination of cyanosis suggests a genetic determinant.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Coronary Artery Disease III: Clinical Manifestations
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

